 | Up a level |
Number of items: 2.
Pettitt, AR, Polydoros, F, Dodd, J, Oates, M, Lin, K, Kalakonda, N, McCarthy, H, Bloor, A, Schuh, A, Duncombe, A et al (show 6 more authors)
(2016)
FINAL RESULTS OF THE NCRI CLL210 TRIAL OF ALEMTUZUMAB, DEXAMETHASONE AND LENALIDOMIDE IN PATIENTS WITH HIGH-RISK CLL (ORIGINAL PROTOCOL).
.
Eyre, TA, Clifford, R, Bloor, A, Boyle, L, Roberts, C, Cabes, M, Collins, GP, Devereux, S, Follows, G, Fox, CP et al (show 12 more authors)
(2016)
NCRI phase II study of CHOP in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndrome.
BRITISH JOURNAL OF HAEMATOLOGY, 175 (1).
pp. 43-54.